Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADME Study of [14C]-VVZ-149 in Healthy Male Subjects
NCT04415645Phase 1Completed
- Sponsor
- Vivozon
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of unifiram in postoperative pain, sponsored by Vivozon. Primary endpoints: Mass balance at Day 15, Total radioactivity (TRA) concentration equivalents in plasma at Day 15 and 3 more. Started Feb 2020; status: completed.
02
Drugs
unifiram
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04415645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04415645.